The Signal Transducer and Activator of Transcription 1α and Interferon Regulatory Factor 1 Are Not Essential for the Induction of Indoleamine 2,3-Dioxygenase by Lipopolysaccharide: Involvement of p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways, and Synergistic Effect of Several Proinflammatory Cytokines
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Indoleamine 2,3-dioxygenase (IDO) is induced by interferon (IFN)-gamma-mediated effects of the signal transducer and activator of transcription 1alpha (STAT1alpha) and interferon regulatory factor (IRF)-1. The induction of IDO can also be mediated through an IFN-gamma-independent mechanism, although the mechanism of induction has not been identified. In this study, we explored whether lipopolysaccharide (LPS) or several proinflammatory cytokines can induce IDO via an IFN-gamma-independent mechanism, and whether IDO induction by LPS requires the STAT1alpha and IRF-1 signaling pathways. IDO was induced by LPS or IFN-gamma in peripheral blood mononuclear cells and THP-1 cells, and a synergistic IDO induction occurred when THP-1 cells were cultured in the presence of a combination of tumor necrosis factor-alpha, interleukin-6 or interleukin-1beta. An electrophoretic mobility shift assay using STAT1alpha and IRF-1 consensus oligonucleotide probes showed no STAT1alpha or IRF-1 binding activities in LPS-stimulated THP-1 cells. Further, the LPS-induced IDO activity was inhibited by both p38 mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-kappaB) inhibitors. These findings suggest that the induction of IDO by LPS in THP-1 cells is not regulated by IFN-gamma via recruitment of STAT1alpha or IRF-1 to the intracellular signaling pathway, and may be related to the activity of the p38 MAPK pathway and NF-kappaB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several inflammatory markers have been shown to promote indoleamine-2,3-dioxygenase activation,42”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [42]
In the citing paper
“Another inflammatory pathway by which cytokines may mediate behavioral effects is by activation of IDO (Pemberton et al., 1997, Fujigaki et al., 2006), an enzyme expressed in multiple cell types, including macrophages, dendritic cells, microglia, astrocytes, and neurons (Guillemin et al., 2005c, Huang et al., 2010).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Fujigaki et al., 2006
Citations
Cites
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 937
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Self-citationHuman macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Self-citationIndoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection
Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A. L., Munn, D. H., & Antonia, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10645 · Cited by 365
Ajizian, S. J., English, B. K., & Meals, E. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/314659 · Cited by 345
Saito, K., Suyama, K., Nishida, K., Sei, Y., & Basile, A. S. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12460-5 · Cited by 257
Self-citationRapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration.
Fitzgerald, M. J., Webber, E. M., Donovan, J. R., & Fausto, N. (1995) · PubMed · Cited by 254
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
HEYES, M. P., CHEN, C. Y., MAJOR, E. O., & SAITO, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 214
Self-citationFujigaki, S., Saito, K., Sekikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., & Seishima, M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2313::aid-immu2313>3.0.co;2-s · Cited by 213
Self-citationThomas, S. R., Mohr, D., & Stocker, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36645-0 · Cited by 212
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
Orabona, C., Puccetti, P., Vacca, C., Bicciato, S., Luchini, A., Fallarino, F., Bianchi, R., Velardi, E., Perruccio, K., Velardi, A., et al. (2006) · Blood · doi:10.1182/blood-2005-10-4077 · Cited by 188
A mechanism for increased quinolinic acid formation following acute systemic immune stimulation
Saito, K., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82284-0 · Cited by 184
Self-citationOverexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease
Wolf, A. M., Wolf, D., Rumpold, H., Moschen, A. R., Kaser, A., Obrist, P., Fuchs, D., Brandacher, G., Winkler, C., Geboes, K., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.004 · Cited by 158
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes
Musso, T., Gusella, G., Brooks, A., Longo, D., & Varesio, L. (1994) · Blood · doi:10.1182/blood.v83.5.1408.1408 · Cited by 157
Hassanain, H. H., Chon, S. Y., & Gupta, S. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53504-3 · Cited by 135
Ropert, C., de Almeida, I. C., Closel, M., Travassos, L. R., Ferguson, M. A. J., Cohen, P., & Gazzinelli, R. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3423 · Cited by 124
Saito, K., Nowak, T. S., Suyama, K., Quearry, B. J., Saito, M., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07443.x · Cited by 116
Self-citationKonan, K. V., & Taylor, M. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19140 · Cited by 116
Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase
Wang, S.-W., Pawlowski, J. E., Wathen, S. T., Kinney, S. D., Lichenstein, H. S., & Manthey, C. L. (1999) · Inflammation Research · doi:10.1007/s000110050499 · Cited by 102
Morita, T., Saito, K., Takemura, M., Maekawa, N., Fujigaki, S., Fujii, H., Wada, H., Takeuchi, S., Noma, A., & Seishima, M. (2001) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/0004563011900461 · Cited by 94
Self-citationTHE role of indoleamine 2,3‐dioxygenase in the anti‐tumour activity of human interferon‐γ in vivo
Burke, F., Knowles, R. G., East, N., & Balkwill, F. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600117 · Cited by 94
Yuan, W., Collado-Hidalgo, A., Yufit, T., Taylor, M., & Varga, J. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199810)177:1<174::aid-jcp18>3.0.co;2-d · Cited by 83
Tryptophan degradation in transplanted tumor cells undergoing rejection.
Yoshida, R., Park, S. W., Yasui, H., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2819 · Cited by 78
CHON, S. Y., HASSANAIN, H. H., PINE, R., & GUPTA, S. L. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.517 · Cited by 77
Takikawa, O., Habara-Ohkubo, A., & Yoshida, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.4.1246 · Cited by 70
Nitration and Inactivation of IDO by Peroxynitrite
Fujigaki, H., Saito, K., Lin, F., Fujigaki, S., Takahashi, K., Martin, B. M., Chen, C. Y., Masuda, J., Kowalak, J., Takikawa, O., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.372 · Cited by 68
Self-citationLi, N., & Oberley, T. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199810)177:1<148::aid-jcp16>3.0.co;2-9 · Cited by 67
Alberati-Giani, D., & Cesura, A. M. (1998) · Amino Acids · doi:10.1007/bf01345271 · Cited by 41
HISSONG, B. D., & CARLIN, J. M. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.387 · Cited by 40
Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase
Habara-Ohkubo, A., Shirahata, T., Takikawa, O., et al. (1993) · Infection and Immunity · doi:10.1128/iai.61.5.1810-1813.1993 · Cited by 39
Seishima, M., Seishima, M., Takemura, M., et al. (1998) · PubMed · Cited by 20
Self-citation
Cited by
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Metadata
- Authors
- Fujigaki, H., Saito, K., Fujigaki, S., Takemura, M., Sudo, K., Ishiguro, H., & Seishima, M.
- Affiliations
- Gifu University (JP)
- National Institutes of Health (US)
- Venue
- The Journal of Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-01
- Volume
- 139
- Issue
- 4
- Pages
- 655-662
- ISSN
- 0021-924X (ISSN-L)
- 1756-2651
- OpenAlex
- W2070825197
- Cited by
- 222
- References
- 32
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 8 · 2023: 10 · 2022: 7 · 2021: 17 · 2020: 6 · 2019: 13 · 2018: 8 · 2017: 8 · 2016: 14 · 2015: 19 · 2014: 8 · 2013: 13 · 2012: 15
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, IRF1, p38 MAPK, NF-κB, inflammatory cytokines, TNF-α, interleukin-6, IL-1β, THP-1 cells, peripheral blood mononuclear cells, tryptophan metabolism
- MeSH terms
- Cell Line, Enzyme Activation, Enzyme Inhibitors, Humans, Interferon-gamma, Lipopolysaccharides, Models, Biological, Tumor Necrosis Factor-alpha, Cytokines, NF-kappa B, U937 Cells, Electrophoretic Mobility Shift Assay, Cell Line, Tumor, p38 Mitogen-Activated Protein Kinases, Indoleamine-Pyrrole 2,3,-Dioxygenase, STAT1 Transcription Factor, Interferon Regulatory Factor-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.